Thrombocytosis with acquired von Willebrand disease in an adolescent with sickle cell disease

Thrombocytosis with acquired von Willebrand disease in an adolescent with sickle cell disease

Abstract Thrombocytosis is common in sickle cell disease and may contribute to vaso‐occlusion. Hydroxyurea treats extreme thrombocytosis. Acquired von Willebrand disease should be considered prior to aspirin therapy.

Bibliographic Details
Main Authors: Marianne E. M. Yee, Glaivy Batsuli, Satheesh Chonat, Sunita Park
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Clinical Case Reports
Subjects:
acquired Von Willebrand disease
priapism
sickle cell disease
thrombocytosis
Online Access:https://doi.org/10.1002/ccr3.3556
Description
Summary:Abstract Thrombocytosis is common in sickle cell disease and may contribute to vaso‐occlusion. Hydroxyurea treats extreme thrombocytosis. Acquired von Willebrand disease should be considered prior to aspirin therapy.
ISSN:2050-0904

Similar Items